[Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects]

Rev Iberoam Micol. 2014 Apr-Jun;31(2):137-40. doi: 10.1016/j.riam.2013.09.003. Epub 2013 Sep 23.
[Article in Spanish]

Abstract

Background: Candida albicans has a variety of virulence factors, including secreted aspartyl proteases, which are determinant factors in the pathogenesis of this yeast in immunocompromised patients.

Aims: Proteinase activity was identified in C. albicans strains isolated from the oral cavity of immunocompromised patients with cancer, diabetes and HIV+, with oral candidiasis and in healthy subjects.

Methods: Two hundred and fifty C. albicans strains were analyzed, distributed in 5 different groups: patients with cancer, diabetes, HIV+, with oral candidiasis and healthy subjects.

Results: Proteolytic activity was identified in 46% of the strains from cancer patients, 54% from HIV+ patients, 60% from diabetics, 70% from oral candidiasis patients, and 42% from healthy subjects. Activity was higher in strains from immunocompromised and oral candidiasis patients than in healthy subjects. Differences were observed between the candidiasis-healthy, candidiasis-HIV+, and diabetic-healthy groups. No differences were observed between the oral candidiasis, diabetes and cancer patients, between the diabetes and HIV+ patients, or between the cancer patients, HIV+ patients and healthy subjects.

Conclusions: The present results suggest that although secreted aspartyl proteases are important in the pathogenesis of C. albicans, their activity depends on host conditions.

Keywords: Cancer; Candida albicans; Candidiasis oral; Cáncer; Diabetes; Factores de virulencia; Healthy carriers; Human immunodeficiency virus; Oral candidiasis; Portadores sanos; Proteinasa; Proteinase; Virulence factors; Virus de la inmunodeficiencia humana.

MeSH terms

  • Candida albicans / enzymology*
  • Candida albicans / isolation & purification
  • Candida albicans / pathogenicity
  • Candidiasis, Oral / microbiology*
  • Carrier State / microbiology
  • Diabetes Complications / microbiology
  • Fungal Proteins / analysis*
  • HIV Infections / microbiology
  • Humans
  • Immunocompromised Host*
  • Mexico
  • Mouth / microbiology*
  • Neoplasms / complications
  • Peptide Hydrolases / analysis*
  • Virulence

Substances

  • Fungal Proteins
  • Peptide Hydrolases